S U M M A R Y Collagen XVII (BP180) is a hemidesmosomal transmembrane component that has been hypothesized to participate in keratinocyte adhesion and motility. Using immunohistochemical (IHC) and in situ hybridization (ISH) methods, we showed downregulation of collagen XVII in basal cells in mild dysplasias and upregulation in suprabasal keratinocytes in moderate and severe dysplasias as well as in the central cells of grade II and III squamous cell carcinomas (SCCs). Overexpression of collagen XVII was found at the invasive front of the tumors. Collagen XVII and its cleaved ectodomain were characterized from culture extracts and precipitates of oral keratinocytes, tongue carcinoma cells, and tumor tissue extract. Malignant cell lines exhibited increased collagen XVII expression in immunoblotting analysis. In oral keratinocytes, collagen XVII gene expression was significantly induced by PMA but not by the inflammatory cytokines TGF-␤ 1, TNF-␣ , EGF, IL-1 ␤ , and IL-6. These results indicate altered expression of collagen XVII at different stages of carcinogenesis and suggest a correlation between overexpression of collagen XVII and tumor progression. The reduced collagen XVII expression at the early step of carcinogenesis may reflect disturbed keratinocyte adhesion to the basement membrane.
H emidesmosomes are multi-protein junctional complexes that participate in adhesion of epithelial cells to the basement membrane and in maintenance of tissue integrity. Recent studies have revealed novel functions of the hemidesmosome components in signal transduction, including effects on cell behavior in processes such as wound healing, cell migration, and tumor invasion (Borradori and Sonnenberg 1999; Nievers et al. 1999) . Although the precise interactions and functions of the hemidesmosome components are not completely understood, it is generally accepted that the basement membrane zone represents the first barrier in tumor cell invasion. In epithelial cancers, aberrant expression of the hemidesmosome-associated proteins BP230, ␣ 6 ␤ 4 integrin, laminin-5, and collagen XVII has been reported, indicating their role in tumor development and invasion (Kainulainen et al. 1997; Chopra et al. 1998; Skyldberg et al. 1999; Herold-Mende et al. 2001; Parikka et al. 2001) .
Collagen XVII, a hemidesmosome component, is a type II transmembrane protein composed of a globular cytoplasmic domain and a large extracellular domain containing multiple collagenous repeats (Giudice et al. 1992; Li et al. 1993) . The cytoplasmic domain of collagen XVII associates with ␤ 4 integrin and the extracellular NC1 domain with the ␣ 6 and ␤ 1 integrins (Borradori et al. 1997; Schaapveld et al. 1998; Tasanen et al. 2000) . The function of the membranebound collagen XVII in the anchoring of epithelial cells to the basement membrane is supported by the fact that mutations in the collagen XVII gene lead to junctional epidermolysis bullosa (McGrath et al. 1995; Schumann et al. 1997 ). In addition, certain au-toimmune blistering skin diseases are associated with an autoimmune response to collagen XVII (Balding et al. 1996; Zillikens et al. 1997; Schumann et al. 2000) .
A 120-kD peptide is proteolytically released from the extracellular region of collagen XVII into the extracellular matrix Schäcke et al. 1998) . Although the biological function of this soluble peptide remains to be established, ectodomain shedding is likely to participate in regulation of keratinocyte-matrix interactions. According to recent studies, collagen XVII ectodomain is associated with keratinocyte spreading and migration (Nykvist et al. 2001; Franzke et al. 2002) . To resolve if the expression pattern of collagen XVII is altered at various stages of squamous cell carcinogenesis, we examined precancerous lesions and squamous cell carcinomas (SCCs) of the oral cavity as well as tongue SCC cell lines. We demonstrate upregulation of collagen XVII gene expression in moderate and severe dysplasias, in SCC tumors, and in cultured malignant cell lines.
Materials and Methods

Tissue Samples
Thirty-five cases of tongue SCC, 25 cases of epithelial dysplasias, and four cases of fibrotic hyperplasia were obtained from the archives of the Department of Pathology, Oulu University Hospital. The epithelial dysplasias were graded histologically by an oral pathologist (TS) as mild ( n ϭ 9), moderate ( n ϭ 10), or severe ( n ϭ 6) and the carcinoma samples as well ( n ϭ 15), moderately ( n ϭ 15), or poorly ( n ϭ 5) differentiated. Five samples of normal buccal mucosa were collected from healthy volunteers as normal controls.
Antibodies
For immunostainings and immunoblotting, the following polyclonal collagen XVII antibodies were used: NC16a, raised against the juxtamembranous NC16 domain, i.e., amino acids 490-567 (GenBank accession number M911669), Ecto-3, raised against the amino acids 1365-1413 , and a novel antibody, Ecto-5, recognizing the most distal 51 amino acids of the C-terminus (Franzke et al. 2002) .
Immunostaining
Immunoperoxidase staining of the paraffin sections was performed as described earlier (Parikka et al. 2001) . Antigen retrieval was performed by microwave processing in glycine buffer (pH 3.6, twice for 5 min), after which the sections were incubated overnight with the NC16a antibody diluted 1:1500. Negative control samples were treated with preimmune rabbit serum instead of the antibody.
To calculate a score for immunostaining, the intensity of the immunostaining signal and the number of positive cells were quantified by light microscopy (Bachmeier et al. 2000) . The grading was performed on 10 randomly selected light microscopy fields ( ϫ 400 magnification) in each tissue section. The basal and suprabasal cells in normal mucosa and dysplasias were evaluated separately, as were the central and peripheral carcinoma cells in SCCs. Statistical analysis was performed by one-way ANOVA and Schäffe's f -test. Statistical significance was set at p Ͻ 0.05.
Western Blotting Analysis
Protein samples, including immunoprecipitated media and cell extracts from oral keratinocytes (IHGKs) and SCC cells (SCC-25, HSC-3), as well as carcinoma tissue extract were separated on 12% SDS-PAGE gel and transferred onto nitrocellulose. Nonspecific antibody binding was blocked with 2% milk in Tris-buffered saline (TBS) (30 min). The polyclonal antibodies NC16a (1:1000), Ecto-5 (1:500), and Ecto-3 (1:500) were diluted in 2% milk-TBS and incubated overnight with the membrane. After washes and incubation with the secondary antibody, the collagen XVII signal was detected by NBT-BCIP substrate.
Semiquantitative analysis of collagen XVII in extracts of IHGK, SCC-25, and HSC-3 cells was performed by ECL Western blotting. The samples were run on a 12% SDS-PAGE gel and transferred onto Immobilon-P nitrocellulose membrane (Millipore; Bedford, MA). Nonspecific binding of the antibody was blocked by incubation with 10% milk in TBS for 60 min. The membrane was washed with TBS and incubated overnight with polyclonal XVIIcol antibody NC16a diluted 1:500. After washes in TBS, the filter was incubated with peroxidase-conjugated swine anti-rabbit immunoglobulins (1:500; DAKO, Glostrup, Denmark) for 60 min, washed again, and incubated with avidin-biotinylated horseradish peroxidase (ABComplex/HRP; DAKO) for 60 min. The filter was treated with ECL detection solution for 1 min, and collagen XVII was visualized by X-ray film exposure (Hyperfilm-ECL; Amersham Life Science, Poole, UK). The relative amount of collagen XVII in the samples was calculated by scanning the bands on the X-ray film and dividing the scanning unit values by the respective values of the total loaded protein visualized by Coomassie staining (ScionImage PC; Scion Corporation, Annapolis, MD).
In Situ Hybridization
To prepare non-radioactive ISH probes with the DIG RNA Labeling kit (Boehringer Mannheim; Mannheim, Germany), a cDNA fragment, Ecto-4, covering the amino acids 1365-1497 of the collagen XVII ectodomain was amplified from keratinocyte mRNA with reverse transcriptase polymerase chain reaction (PCR) (Titan reverse transcriptase PCR; Roche Molecular Biochemicals, Mannheim, Germany) with the sense primer 5 Ј -CGCGGATCCGCTGACTTTGCTGG-AGATCT-3 Ј and the antisense primer 5 Ј -CGCGGAATTC-CGGCTTGACAGCAATACT-3 Ј and, after digestions with BamHI and EcoRI (restriction sites underlined), cloned into the pGEM.4Z vector (Promega; Madison,WI). The probe in the sense orientation was used as a control for nonspecific hybridization. ISH was carried out as described earlier (Parikka et al. 2001) . The antisense or sense probe was diluted 300 ng/ml and hybridized on the sections at 58C.
Cell Culture Experiments
IHGK cells (HPV-16-transformed oral keratinocyte cells; a kind gift from Prof. Dolphin Oda, Seattle, WA) (Oda et al. 1996) were cultured in serum-free keratinocyte medium supplemented with bovine pituitary extract, recombinant epidermal growth factor (Gibco BRL; Grand Island, NY), 1% penicillin, and 0.5% nystatin. Human SCC cell lines SCC-25 (tongue, ATCC, CRL-1628, Rockville, MD) and HSC-3 (tongue; Japan Health Science Research Resources Bank, JRCB 0623) were cultured in 1:1 DMEM and Ham's Nutrient Mixture F-12, containing 10% FCS, 100 IU/ml penicillin, 100 g/ml streptomycin, 50 IU/ml nystatin, 25 g/ml amphotericin-B, and 0.4 g/ml hydrocortisone. EA.hy926 cells (immortalized human endothelial cells; a generous gift from Prof. Cora-Jean S. Edgell, Raleigh, NC) were cultured in DMEM containing 10% FBS and HAT supplement (Gibco BRL). The human myeloma cell line RPMI 8226 (ATCC no. CCL-155) was cultured in RPMI 1640 medium (Gibco BRL, Basel, Switzerland) supplemented with 10% NCS, 1% lactate glutamate, and 1% penicillin-streptomycin. Cells were grown in a humidified atmosphere at 37C with 5% CO 2 , culture media were replaced once every 2-3 days, and subcultures were obtained by trypsin/EDTA treatment. At 48 hr before and during the experiments, cells were cultured in the presence of 50 g/ml ascorbic acid, and the supplements were excluded from the keratinocyte medium.
To assess the regulation of collagen XVII gene expression, subconfluent cells were incubated with TGF-␤ 1 (1/5/10 ng/ml), PMA (30/60/100 ng/ml), TNF-␣ (5/20/50 ng/ml), EGF (0.1/1/10 ng/ml), IL-1 ␤ (10/20/50 ng/ml), or IL-6 (10/ 20/50 ng/ml). After 24-hr incubation, total RNA was isolated from the cells using a Trizol kit (Gibco BRL; Life Technologies, Roskilde, Denmark). Each experiment was repeated six times.
Protein Extractions
The cultured cells and the conditioned media were processed separately for protein extractions. For immunoprecipitation of the shed ectodomain of collagen XVII, the medium was collected, cooled, centrifuged to remove cell debris, and supplemented with 1 mM Pefablock (Merck; Darmstadt, Germany) and 1 mM N -ethylamide (Sigma-Aldrich; Deisenhofen, Germany). Before immunoprecipitation, 0.2 g of protein A-Sepharose (Amersham Pharmacia Biotech; Uppsala, Sweden) was prepared as indicated by the supplier, washed once with PBS, once with PBS-0.5% Tween, and once again with PBS. Then 50 l of the NC16a antibody was added to protein A-Sepharose in 0.5 ml of PBS and rotated for 3 hr at 4C. The protein A-Sepharose/antibody complex was washed three times as above, and 30 ml of medium was added to the antibody complexes and rotated at 4C overnight. After three washes as above, the pellet was packed into a small column using 50 mM Tris-HCl, pH 7.0, at RT as column buffer. After extensive washing with the same buffer, the ectodomain of collagen XVII was eluted using 6 ml of 0.1 M glycine buffer, pH 3.0, at RT, and the pH of the fractions was neutralized with 1 M Tris-HCl, pH 9.0, at RT, immediately after elution.
The full-length collagen XVII was extracted from the cell layer as described earlier (Schäcke et al. 1998 ). In brief, the cell layer was incubated with extraction buffer containing detergent (1% Nonidet P-40) and proteinase inhibitors (14 g/ml chymostatin, 7 g/ml antipain, 7 g/ml leupeptin, 14 g/ml pepstatin, 1 mM Pefablock, and 10 l/ml NEM). The lysate was scraped from the dish and centrifuged to remove the cell debris. The frozen SCC tissue (approximately 50 mm 3 ) was homogenized in 2 ml of extraction buffer with a glass homogenizer and incubated for 3 hr at 4C in a mixer. The tissue debris was removed by centrifugation at 14,000 ϫ g for 30 min at 4C. The extracts and the medium concentrate were analyzed by immunoblotting.
RT-PCR
Four ng of human total mRNA extracted from immortalized keratinocytes of oral cavity (IHGK) and skin (HaCat), SCC cells (SCC-25, HSC-3), endothelial cells (EA.hy926), and myeloma cells (RPMI 8226) was reverse-transcribed using Superscript II RnaseH Ϫ Reverse Transcriptase (Gibco BRL) and random hexamer primers. A human cDNA fragment of 230 bp corresponding to the NC16a domain of collagen XVII (amino acids 490-567) was amplified using the sense primer 5 Ј -GAGGAGGTGAGGAAGCTGAA-3 Ј and the antisense primer 5 Ј -TCGGAGATTTCCATTTTCC-3 Ј . The PCR reaction was performed in a thermal reactor with thermostable Dynazyme DNA polymerase (Finnzymes Oy; Espoo, Finland), using 35 cycles. The PCR products were analyzed by electrophoresis on 1% agarose gel containing 1.0 g/ml ethidium bromide.
Ribonuclease Protection Assay (RPA)
RPA was carried out using an RPA IIITM Ribonuclease Protection Assay Kit (Ambion; Austin, TX) according to the manufacturer's instructions. [ ␣ -32P]-UTP-labeled 228-bp NC16a cRNA probe (nucleotides 4198-4596) was hybridized with 10 g of total RNA. The protected doublestranded RNA fragment was run on a 5% denaturing polyacrylamide gel and visualized on an X-ray film (Kodak; Rochester, NY). A 115-bp 18S cRNA probe (Ambion) was included in the hybridization reaction as an internal control for semiquantitative analysis of the protected collagen XVII fragment. Statistical analysis was performed by Student's t -test and statistical significance was set at p Ͻ 0.05.
Results
Enhanced Expression of Collagen XVII in Epithelial Dysplasias and SCCs
Distribution of collagen XVII in oral precancers and SCCs was studied by immunoperoxidase staining with NC16a, a polyclonal antibody against the extracellular juxtamembranous NC16a domain. In healthy oral mucosa, immunostaining of collagen XVII was seen at the cell membranes surrounding the basal keratinocytes ( Figure 1A) . In samples of non-dysplastic fibrotic hyperplasia of oral mucosa the staining pattern was similar to that of the healthy controls (not shown). Surprisingly, in all mild dysplasias, collagen XVII staining was mostly missing from the basal keratinocytes, and faint positive signals were seen only in some small areas ( Figure 1B) . In all moderate and severe dysplasias, in some areas an intense staining sig-nal was detected throughout all layers of the epithelium, but there were also areas without any staining, even in the basal cells ( Figures 1C and 1D) . In grade I oral SCCs, the immunoreaction of collagen XVII was intense and mainly located in the peripheral carcinoma cells of tumor nests ( Figure 1E ). Different staining patterns were observed in grade II and III tumors, as the signal was also detected in the central carci-noma cells ( Figure 1G ). In all tumors, the malignant cells at the invasive front, the most peripheral area of the tumor invading into the surrounding tissue, displayed intense staining ( Figure 1H ).
Immunostaining scores were calculated for each tissue section by grading the positive cells and the staining intensity to quantify the immunostainings. Statistical analyses revealed a significantly higher score for collagen XVII level in suprabasal keratinocytes of moderate and severe displasia compared to mild dysplasias or normal mucosa ( Figure 3A) . The scores were significantly lower for the basal cells of mild and severe dysplasias than for normal mucosa ( Figure 3A) . The score for basal cells in moderate dysplasias was clearly but not significantly lower than that of the normal control group ( p ϭ 0.063) ( Figure 3A) . The immunostaining scores for the basal cells of moderate and severe dysplasias were significantly higher compared to mild dysplasias ( Figure 3A) . In grade II and III SCCs, the score for the central cells of tumor islands was significantly higher compared to grade I tumors ( Figure 3B ). There was no significant difference between the scores for the peripheral carcinoma cells in grade I and grade II/III tumors ( Figure 3B ).
Increased Collagen XVII mRNA Expression in Epithelial Dysplasias and SCCs
RNA expression was studied by non-radioactive ISH with an Ecto-4 RNA probe corresponding to the 133 most C-terminal amino acids of collagen XVII. The epithelium of healthy oral mucosa contained no detectable mRNA signal (Figure 2A) . In mild dysplasias, too, the signal for collagen XVII was mainly negative, except for some areas showing a weak signal in the basal epithelial cells ( Figure 2B) . In contrast, an extremely strong mRNA signal was observed locally in all epithelial layers of moderate and severe dysplasias ( Figures 2C and 2D) . In SCCs the collagen XVII mRNA expression pattern was in line with the results of the immunostainings. The signal was detected in the central and peripheral cells of tumor islands ( Figures 2E and 2G) . The most intense mRNA signal for collagen XVII was seen in the carcinoma cells at the invasive tumor front ( Figure 2G ).
Collagen XVII mRNA Expression in Cultured Oral Keratinocytes and SCC Cells
Oral keratinocytes (IHGK) and two tongue SCC cell lines (SCC-25, HSC-3) were examined for collagen XVII mRNA synthesis by RT-PCR, the amplified sequence covering the extracellular NC16a domain. Collagen XVII mRNA could be demonstrated in the oral keratinocyte cell line (IHGK) and in both of the oral SCC cell lines (SCC-25, HSC-3) ( Figure 4A ). Skin keratinocytes (HaCat) served as a positive control. No signal was detected in the mRNA of two negative control cell lines, immortalized endothelial cells (EA.hy926), and plasmacytoma cells (RPMI 8226) ( Figure 4A ). 
Characterization of Two Forms of Collagen XVII from Cultured Oral Keratinocytes and from SCC Cells and Carcinoma Tissue
Collagen XVII could be extracted from oral keratinocytes (IHGK), two tongue SCC cell lines (SCC-25 and HSC-3), and homogenized SCC tissue. The shed ectodomain was immunoprecipitated from the conditioned media with the NC16a antibody. For immunoblotting, three specific polyclonal antibodies were used: NC16a, Ecto-3, and Ecto-5. All three antibodies detected the full-length protein of 180 kD in the cell extracts, while the 120-kD soluble ectodomain was found in the cell media precipitates ( Figure 4B) . A signal for the 120-kD peptide was obtained in IHGK, SCC-25, and HSC-3 cell extracts and also in the carcinoma tissue by the NC16a antibody ( Figure 4B ), which has strong affinity for the shed peptide . Only the novel Ecto-5 antibody detected the full-length collagen XVII from the SCC tissue sample ( Figure 4B ). An additional 97-kD band, representing a degradation product of collagen XVII, was found in the SCC-25 and HSC-3 cell extracts and medium precipitates by the NC16a antibody ( Figure 4B ).
Upregulation of Collagen XVII in SCC Cells
The relative level of collagen XVII synthesis in cultured oral keratinocytes and in two tongue SCC cell lines, SCC-25 and HSC-3, was determined by Western blotting analyses ( Figure 4C ). In HSC-3 cells, Western blotting with NC16a antibody showed an approximately 1.3-fold collagen XVII expression level compared to IHGK cells ( Figure 4C ). In SCC-25 cells, the level of collagen XVII was approximately 1.6-fold compared to IHGK cells ( Figure 4C ).
Collagen XVII Expression Is Induced by PMA
The regulation of collagen XVII gene expression was studied by treating IHGK cells with different concentrations of cytokines TNF-␣ , EGF, TGF-␤ , IL-1 ␤ , IL-6, and PMA. The level of collagen XVII mRNA synthesis was measured semiquantitatively by the ribonuclease protection assay (RPA) ( Figure 5A ). Incubation of keratinocytes with TNF-␣ (20 ng/ml) or TGF-␤ 1 (1 ng/ml) led to a 1.35-fold collagen XVII mRNA level compared to the control level ( Figure 5B ). Treatment with PMA (100 ng/ml) caused a 1.5-fold induction in collagen XVII mRNA expression, which is significantly higher than the steady-state level ( p Ͻ 0.05) ( Figure 5B ). There were no significant changes in collagen XVII mRNA synthesis in the cells treated with EGF, IL-1 ␤ , or IL-6 ( Figure 5B ).
Discussion
These results show downregulation of collagen XVII in basal cells in mild dysplasias and upregulation in suprabasal keratinocytes in moderate and severe dysplasias as well as in the central cells of grade II and III carcinomas. Collagen XVII upregulation in malignant cells was confirmed by in vitro studies. Regulation of collagen XVII gene expression by cytokines was studied in oral keratinocytes, revealing clear induction by a tumor promoter, PMA.
In normal oral mucosa, collagen XVII was expressed exclusively in the basal keratinocytes, representing its role as a hemidesmosomal component. Immunostaining was observed on the lateral and basal surfaces of the basal cells, which is typical of collagen XVII and ␣ 6 ␤ 4 integrin, the transmembrane components of the hemidesmosome . Collagen XVII mRNA synthesis appears to be fairly low in normal basal keratinocytes, since no ISH signal could be visualized in oral mucosa. However, in mild dysplasias, basal cells displayed a weak positive mRNA signal, although a loss of collagen XVII immunostaining signal was observed in these cells. This might suggest increased turnover and degradation of collagen XVII at the protein level. Previously, we have reported reduced collagen XVII expression in the peripheral cells of carcinoma islands in solid and keratotic basal cell carcinomas (BCCs) and in the basal cells of invading buds in superficial BCCs (Parikka et al. 2001) . The downregulation of collagen XVII in the basal keratinocytes or in the peripheral cells of tumor islands is likely to coincide with the disassembly of hemidesmosomes, which is an essential step in keratinocyte migration and carcinoma cell invasion.
In moderate and severe oral dysplasias, collagen XVII expression was notably upregulated, because areas of cytoplasmic immunoreaction and mRNA signal covering all the layers of the epithelium were detected. Earlier, a similar staining pattern has been reported for collagen XVII in Bowen's disease (Yamada et al. 1996) . Downregulation of collagen XVII and other hemidesmosome components has been previously detected in vivo in prostate cancer and in the invasive cells of ductal mammary carcinoma, which are epithelial cancers not originating from stratified epithelia (Bergstraesser et al. 1995; Nagle et al. 1995) . However, upregulation of hemidesmosome components has been reported in a variety of SCCs, including carcinomas of head and neck, lung, cervix, esophagus, and skin (Yamada et al. 1996; Herold-Mende et al. 2001 ). In the present investigation, too, immunostaining and ISH of 35 tongue SCCs revealed upregulated collagen XVII expression, even in the absence of hemidesmosome formation. At the invasive front of the tumors, the immunoreaction was intense and not restricted to the peripheral carcinoma cells, which are in contact with the basement membrane-like structure surrounding the neoplastic islands. The fact that collagen XVII was upregulated in carcinoma cells at the invasive front of malignant tumors indicates a role of collagen XVII in the regulation of carcinoma cell migration. This result is in line with a recent study describing upregulation and altered distribution of two other hemidesmosome components, BP230 and ␣6␤4 integrin, in the areas of invasive growth of head and neck SCCs (Herold-Mende et al. 2001) . Interestingly, in our study, grade II/III SCCs displayed upregulated collagen XVII expression in the central carcinoma cells in the other parts of the tumor as well, which may suggest a correlation between the upregulation of collagen XVII and tumor progression.
We demonstrated by RT-PCR collagen XVII mRNA expression in two tongue SCC cell lines, HSC-3 and SCC-25, as well as in immortalized oral IHGK keratinocytes. Collagen XVII protein could also be extracted from these cell lines and was characterized by immunoblotting with three antibodies. For the first time, full-length collagen XVII and the shed ectodomain of 120-kD were extracted from SCC tissue. Both the transmembrane 180-kD collagen XVII and the soluble ectodomain have previously been extracted from skin using a similar method (Schäcke et al. 1998 ). The elevated expression of collagen XVII in SCC observed by IHC and ISH was confirmed in vitro by immunoblotting, which revealed an induced collagen XVII level in HSC-3 cells and SCC-25 cells compared to immortalized keratinocytes. In a recent study, expression of collagen XVII was studied semiquantitatively in different nasopharyngeal carcinoma cell lines by RT-PCR and Western blotting, showing wide dispersion between cell lines (Lo et al. 2001) .
In this study, treatment with the inflammatory cytokines TNF-␣, EGF, TGF-␤1, IL-1␤ and IL-6, did not result in a significant increase in collagen XVII mRNA expression in oral keratinocytes. However, stimulation with a phorbol ester, PMA, caused a clear induction of collagen XVII mRNA. PMA is a potent tumor promoter capable of inducing several genes that have a role in carcinogenesis and tumor invasion (Blumberg 1981) . The laminin-5 ␥2 chain gene promoter is one of the targets for PMA activation, occurring via inter-Figure 4 (A) RT-PCR analysis. Expression of collagen XVII mRNA was detected in oral keratinocytes (IHGK) and two tongue SCC cell lines (SCC-25 and HSC-3) as well as in the positive control cells, skin keratinocytes (HaCat). Endothelial cells (EA.hy926) and plasmacytoma cells (RPMI 8226) were included as negative controls. (B) Western blot. Collagen XVII was extracted from cultured oral keratinocytes, two SCC cell lines, and homogenized tongue carcinoma tissue, and immunoprecipitated from the conditioned media. The extracts and the precipitates were analyzed by immunoblotting with three specific collagen XVII antibodies: NC16a, Ecto-3 and Ecto-5. (C) ECL Western blot. Collagen XVII levels in extracts of oral keratinocytes (IHGK) and two malignant cell lines (SCC-25, HSC-3) were analyzed semiquantitatively. Collagen XVII level was 1.3-fold in HSC-3 cells and 1.6-fold in SCC-25 cells compared to IHGK cells. action with the activator protein 1 complexes (Olsen et al. 2000) . It is known that the biological effect of phorbol esters is mediated by activation of protein kinase C, resulting in various changes in transcription patterns. There is evidence that PMA-induced protein kinase C activation leads to changes in the organized distribution of collagen XVII and to detachment from hemidesmosomes (Kitajima et al. 1992) . Upregulation and reorganization of collagen XVII in response to PMA stimulation are of particular interest because this suggests a possible role for collagen XVII in carcinogenesis and tumor progression.
Upregulation of collagen XVII and other hemidesmosome-associated proteins in central carcinoma cells not expressing hemidesmosomes may imply an alternative function of these molecules, in addition to their known role in keratinocyte-matrix adhesion. In addition, ␣6␤4 integrin has a significant role in signaling pathways stimulating cell migration and invasion (Mercurio et al. 2001) . As a transmembrane molecule, collagen XVII is also likely to participate in signal transduction, this idea being supported by the structure of the collagen XVII cytoplasmic domain contain-ing several putative phosphorylation sites (Hopkinson et al. 1992) . The collagen XVII extracellular COL15 domain has been shown to promote keratinocyte spreading, suggesting that the shed 120-kD peptide supports epithelial cell migration and invasion. This event seems to be mediated by the ␣ 5 ␤ 1 and ␣ v ␤ 1 integrins, which are expressed by keratinocytes during wound healing and, interestingly, also by carcinoma cells of head and neck SCCs (Larjava et al. 1993; Koivisto et al. 2000; Nykvist et al. 2001) .
The results of this study indicate that collagen XVII expression is abnormal at various stages of multi-step carcinogenesis. The reduced expression in mild dysplasias is likely to reflect the disturbed adhesion of basal keratinocytes to the extracellular matrix. On the other hand, collagen XVII upregulation in the absence of hemidesmosome formation in moderate and severe dysplasias and in grade II and III tumors may reflect an alternative function in addition to the role in cell adhesion. The observation of upregulated collagen XVII gene expression in response to the tumor promoter PMA indicates potential involvement in carcinogenesis and tumor progression. 
